Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)

NCT02393417 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

243

Enrollment

INDUSTRY

Sponsor class

Conditions

Warts

Interventions

BIOLOGICAL: CANDIN
OTHER: Placebo

Sponsor

Nielsen BioSciences, Inc.